Introduction
Mycotoxin binders are commonly used in the feed additive industry to prevent mycotoxicosis in farm animals (Kolosova and Stroka, 2011) . These products are deemed to adsorb mycotoxins in the gut and consequently prevent mycotoxin absorption. Recently, the European Food Safety Authority (EFSA, 2010) stated that too little is known about the interaction between mycotoxin binders and veterinary drugs. Therefore more studies are needed to investigate possible interactions at the level of intestinal absorption. Some suggestions have been made about a possible interaction between macrolide antibiotics and bentonite (EFSA, 2011) , however no specific proof has been put forward yet. The Canadian Bureau of Veterinary Drugs (1992) reported a case of lack of efficiency of tylosin when fed concurrently with bentonite to bovines. Shryock et al. (1994) reported that tilmicosin added to the diet in broiler chickens prevented development of air-sacculitis after inoculation with Mycoplasma gallisepticum, whereas a combined use of tilmicosin and bentonite did not prevent air-sac lesions or clinical symptoms, indicating a possible negative interaction between both. Therefore, the goal of this study was to investigate the capacity of bentonite to bind tylosin, based on specific pharmacokinetic characteristics instead of clinical symptoms which can be biased.
Materials and methods
Sixteen 3 weeks-old broiler chickens (Ross 308) were randomly allocated in two groups of 8 birds. After a one-week acclimatization period, the animals were famished for 12 h. This was followed by an oral intra-crop bolus. One group received a bolus of tylosin (24 mg/kg BW, Tylan Soluble, Elanco Animal Health). The other group received a bolus of tylosin (24 mg/kg BW) and bentonite (0.1 g/kg BW) (Toxisorb Classic, Süd-Chemie). At several time-points after bolus administration, blood was drawn and plasma concentrations of tylosin A were analyzed using a quantitative LC-MS/MS method (Devreese et al., 2012) . Plasma concentration-time profiles were evaluated ( Figure 1 ) and several toxicokinetic parameters were calculated (WinNonlin 6.2, Pharsight Corp., USA) and compared between groups ( 
